| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/17/2001 | US20010001310 Bispecific antibodies for retargeting anticancer cytotoxic lymphocytes |
| 05/17/2001 | US20010001290 Methods for enhancing the production of viral vaccines in cell culture |
| 05/17/2001 | DE19954059A1 Riboflavinsynthase-Gene und Inhibitoren Riboflavin synthase genes and inhibitors |
| 05/17/2001 | DE19952983A1 Verfahren zum Transfer von molekularen Substanzen mit prokaryontischen nukleinsäurebindenden Proteinen A method for the transfer of molecular substances with prokaryotic nucleic acid binding proteins |
| 05/17/2001 | DE19952982A1 Verfahren zur gerichteten Verpackung von molekularen Substanzen in Proteinhüllen Method for the directed packaging of molecular substances in protein shells |
| 05/17/2001 | DE19952957A1 Modulare Transportsysteme für molekulare Substanzen und deren Herstellung und Verwendung Modular Transport systems for molecular substances and their production and use |
| 05/17/2001 | DE19952956A1 Verfahren zur Verbindung von molekularen Substanzen A method for connection of molecular substances |
| 05/17/2001 | CA2428827A1 Human vanilloid receptor gene |
| 05/17/2001 | CA2399371A1 Animal collagens and gelatins |
| 05/17/2001 | CA2396626A1 Methods and compositions for screening using diphtheria toxin constructs |
| 05/17/2001 | CA2391369A1 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 05/17/2001 | CA2391366A1 Computational method for inferring elements of gene regulatory network from temporal patterns of gene expression |
| 05/17/2001 | CA2391279A1 Synthesis of 2'-deoxy-l-nucleosides |
| 05/17/2001 | CA2391129A1 Lentiviral vector transduction of hematopoietic stem cells |
| 05/17/2001 | CA2391009A1 Biosensing using surface plasmon resonance |
| 05/17/2001 | CA2391007A1 Novel human atpase proteins and polynucleotides encoding the same |
| 05/17/2001 | CA2391003A1 Chemical inducible promoters used to obtain transgenic plants with a silent marker |
| 05/17/2001 | CA2390995A1 Recombinant gelatin in vaccines |
| 05/17/2001 | CA2390834A1 Transplant/implant device and method for its production |
| 05/17/2001 | CA2390740A1 Melanocortin-4 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight |
| 05/17/2001 | CA2390723A1 Melanocortin-3 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight |
| 05/17/2001 | CA2390719A1 Stress-resistant oversized transgenic plants capable of growing in salinized soil |
| 05/17/2001 | CA2390650A1 Novel human proteases and polynucleotides encoding the same |
| 05/17/2001 | CA2390646A1 Compositions and methods for regulating endogenous inhibitor of atp synthase, including treatment for diabetes |
| 05/17/2001 | CA2390568A1 Modification of polysaccharide containing materials |
| 05/17/2001 | CA2390565A1 Macroporous media for biological application prepared by freeze drying |
| 05/17/2001 | CA2390504A1 Cytochrome p450 oxygenases and their uses |
| 05/17/2001 | CA2390491A1 Crib protein zmse1 |
| 05/17/2001 | CA2390438A1 19 human secreted proteins |
| 05/17/2001 | CA2390421A1 24 human secreted proteins |
| 05/17/2001 | CA2390402A1 Novel human kinase protein and polynucleotides encoding the same |
| 05/17/2001 | CA2390374A1 Diagnosis and treatment of malignant neoplasms |
| 05/17/2001 | CA2390306A1 A method for producing seeds having altered protein/fatty acid composition |
| 05/17/2001 | CA2390011A1 Methods and compositions comprising renilla gfp |
| 05/17/2001 | CA2390008A1 Method for modulating nitrilase selectivity, nitrilases obtained by said method and use thereof |
| 05/17/2001 | CA2389954A1 Method of inducing angiogenesis |
| 05/17/2001 | CA2389841A1 Novel nucleic acid molecules encoding cyclised amino acid sequences |
| 05/17/2001 | CA2389813A1 Genes encoding enzymes for lignin biosynthesis and uses thereof |
| 05/17/2001 | CA2389724A1 28 human secreted proteins |
| 05/17/2001 | CA2389722A1 15 human secreted proteins |
| 05/17/2001 | CA2389550A1 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 05/17/2001 | CA2389549A1 Biochannel assay for hybridization with biomaterial |
| 05/17/2001 | CA2389506A1 Nucleic acid-containing complex |
| 05/17/2001 | CA2389330A1 Kringle domain-containing polynucleotides, polypeptides, and antibodies |
| 05/17/2001 | CA2389326A1 35 human secreted proteins |
| 05/17/2001 | CA2389305A1 28 human secreted proteins |
| 05/17/2001 | CA2389204A1 Protein present at the surface of hematopoietic stem cells of the lymphoid line and of nk cells, and uses thereof |
| 05/17/2001 | CA2388914A1 15 human secreted proteins |
| 05/17/2001 | CA2388912A1 6 human secreted proteins |
| 05/17/2001 | CA2388829A1 Pectinophora gossypiella (pink bollworm) bacillus thuringiensis toxin receptor bt-r2 |
| 05/17/2001 | CA2388755A1 Chemical inducible promoter used to obtain transgenic plants with a silent marker and organisms and cells and methods of using same for screening for mutations |
| 05/17/2001 | CA2388753A1 Insect control agent |
| 05/17/2001 | CA2388643A1 Use of lytic toxins and toxin conjugates |
| 05/17/2001 | CA2388477A1 Recombinant gelatins with uniform molecular weight |
| 05/17/2001 | CA2388034A1 Direct mapping of dna chips to detector arrays |
| 05/17/2001 | CA2388019A1 24 human secreted proteins |
| 05/17/2001 | CA2388008A1 29 human secreted proteins |
| 05/17/2001 | CA2387964A1 22 human secreted proteins |
| 05/17/2001 | CA2387959A1 21 human secreted proteins |
| 05/17/2001 | CA2386866A1 Tumor suppressor molecules and methods of use |
| 05/17/2001 | CA2359955A1 Human vanilloid receptor gene |
| 05/17/2001 | CA2325226A1 Use of polypeptides or nucleic acids encoding these for the diagnosis or treatment of skin disorders, and their use for the identification of pharmacologically active substances |
| 05/17/2001 | CA2324414A1 Cytochrome c oxidase enzyme complex |
| 05/16/2001 | EP1099761A1 Use of a class of enzymes to increase the oil content in transgenic organisms |
| 05/16/2001 | EP1099760A1 Bacillus thuringiensis Cry1Ia-Cry1Ba hybrid toxins |
| 05/16/2001 | EP1099759A2 Vibrio cholerae vaccine candidates and methods of their constructing |
| 05/16/2001 | EP1099758A2 Method and host cells for producing two-chain relaxin polypeptide |
| 05/16/2001 | EP1099757A1 Process for the determination of CTp11 and for determining whether a tumor sample has metatastic potential |
| 05/16/2001 | EP1099755A1 Novel gene and transformant carrying the same |
| 05/16/2001 | EP1099708A1 Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same |
| 05/16/2001 | EP1099443A1 Transplant/implant device and method for its production |
| 05/16/2001 | EP1098994A2 Cis acting nucleic acid elements and methods of use |
| 05/16/2001 | EP1098993A1 Quantitative analysis of gene expression using pcr |
| 05/16/2001 | EP1098992A1 Nucleic acid detection method by triple helix formation |
| 05/16/2001 | EP1098991A1 Novel methods for the identification of ligand and target biomolecules |
| 05/16/2001 | EP1098987A1 Method for transformation of animal cells |
| 05/16/2001 | EP1098986A2 A polynucleotide comprising a ubiquitous chromatin opening element (ucoe) |
| 05/16/2001 | EP1098985A1 Genes of the dead box protein family, their expression products and use |
| 05/16/2001 | EP1098984A2 Chorismate biosynthesis enzymes |
| 05/16/2001 | EP1098983A1 Commercial production of proteases in plants |
| 05/16/2001 | EP1098982A2 Glucosylglycerol phosphate synthase gene for producing the low-molecular protective substance glucosylglycerol and the use thereof |
| 05/16/2001 | EP1098981A1 A mutant human hepatitis b viral strain and uses thereof |
| 05/16/2001 | EP1098980A2 $i(STREPTOCOCCUS SUIS) VACCINES AND DIAGNOSTIC TESTS |
| 05/16/2001 | EP1098979A2 Fap alpha-specific antibody with improved producibility |
| 05/16/2001 | EP1098978A1 Gbs toxin receptor |
| 05/16/2001 | EP1098977A2 Methods and compositions for the diagnosis and treatment of body weight disorders, including obesity |
| 05/16/2001 | EP1098976A2 Androgen receptor coactivators |
| 05/16/2001 | EP1098975A1 Orphan cytokine receptor |
| 05/16/2001 | EP1098974A2 Nucleotide sequences and amino acid sequences of secreted proteins involved in angiogenesis |
| 05/16/2001 | EP1098973A1 Human lcb kinase 1 |
| 05/16/2001 | EP1098972A1 Protein similar to neuroendocrine-specific protein, and encoding cdna |
| 05/16/2001 | EP1098971A2 Myotilin, an actin-organizing protein |
| 05/16/2001 | EP1098970A1 Human sbpsapl gene with homology to the prosaposin family of neurotrophic factors |
| 05/16/2001 | EP1098969A2 Use of nucleic acid molecules as antiviral agents |
| 05/16/2001 | EP1098966A1 Methods for purifying nucleic acids |
| 05/16/2001 | EP1098965A1 Process for conversion of germplasm |
| 05/16/2001 | EP1098963A2 Chorismate synthase from plants |
| 05/16/2001 | EP1098962A2 Diacylglycerol acyl transferase proteins |
| 05/16/2001 | EP1098961A1 Interferon inducing genetically engineered attenuated viruses |
| 05/16/2001 | EP1098957A1 Transferring materials into cells using porous silicon |